Xiaomei Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaomei Zhou has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Jiahui Chen
State Key Laboratory of Organ Failure Research, Academy of Orthopedics, Guangdong Province, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China
2 shared publications - Jing Wen
Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China
2 shared publications - Jing Xie
Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
2 shared publications Maegele Mac
Institute for Research in Operative Medicine, Private University of Witten-Herdecke, Cologne Merheim Medical Center, Cologne, Germany
2 shared publicationsMing Zhao
Department of Pathophysiology, Guangdong Provincial Key Laboratory of Shock and Microcirculation Research, Southern Medical University, Guangzhou, China
2 shared publications- Qiancheng Song
Department of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China
2 shared publications
Latest Publications
- Open Access
- 3 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1
Author Correction: Damaged brain accelerates bone healing by releasing small extracellular vesicles that target osteoprogenitors
- 3 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1
Open AccessAuthor Correction: Damaged brain accelerates bone healing by releasing small extracellular vesicles that target osteoprogenitors
- Open Access
- 15 October 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-18
Damaged brain accelerates bone healing by releasing small extracellular vesicles that target osteoprogenitors
Clinical evidence has established that concomitant traumatic brain injury (TBI) accelerates bone healing, but the underlying mechanism is unclear. This study shows that after TBI, injured neurons, mainly those in the hippocampus, release osteogenic microRNA (miRNA)-enriched small extracellular vesicles (sEVs), which targeted osteoprogenitors in bone to stimulate bone formation. We show that miR-328a-3p and miR-150-5p, enriched in the sEVs after TBI, promote osteogenesis by directly targeting the 3′UTR of FOXO4 or CBL, respectively, and hydrogel carrying miR-328a-3p-containing sEVs efficiently repaires bone defects in rats. Importantly, increased fibronectin expression on sEVs surface contributes to targeting of osteoprogenitors in bone by TBI sEVs, thereby implying that modification of the sEVs surface fibronectin could be used in bone-targeted drug delivery. Together, our work unveils a role of central regulation in bone formation and a clear link between injured neurons and osteogenitors, both in animals and clinical settings.
- 15 October 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-18
Open AccessDamaged brain accelerates bone healing by releasing small extracellular vesicles that target osteoprogenitors
Clinical evidence has established that concomitant traumatic brain injury (TBI) accelerates bone healing, but the underlying mechanism is unclear. This study shows that after TBI, injured neurons, mainly those in the hippocampus, release osteogenic microRNA (miRNA)-enriched small extracellular vesicles (sEVs), which targeted osteoprogenitors in bone to stimulate bone formation. We show that miR-328a-3p and miR-150-5p, enriched in the sEVs after TBI, promote osteogenesis by directly targeting the 3′UTR of FOXO4 or CBL, respectively, and hydrogel carrying miR-328a-3p-containing sEVs efficiently repaires bone defects in rats. Importantly, increased fibronectin expression on sEVs surface contributes to targeting of osteoprogenitors in bone by TBI sEVs, thereby implying that modification of the sEVs surface fibronectin could be used in bone-targeted drug delivery. Together, our work unveils a role of central regulation in bone formation and a clear link between injured neurons and osteogenitors, both in animals and clinical settings.